Friday, September 4, 2026

Jerash Holdings And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

January 26, 2021

Jerash Holdings And 3 Other Stocks Have Very High Payout Ratio

We have gathered information regarding stocks with the highest payout ratio up to now. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.

1. Tsakos Energy Navigation Ltd

37.31% Payout Ratio

Tsakos Energy Navigation Limited provides seaborne crude oil and petroleum product transportation services worldwide.

As claimed by Morningstar, Inc., the next dividend payment is on Dec 14, 2020, the estimated forward annual dividend rate is 0.25 and the estimated forward annual dividend yield is 2.82%.

Tsakos Energy Navigation Ltd's sales growth this year is anticipated to be 45.3% and a negative 10% for next year.

Year-on-year quarterly revenue growth grew by 9%, now sitting on 687.89M for the twelve trailing months.

Tsakos Energy Navigation Ltd's sales growth is 26.7% for the current ongoing quarter and negative 3% for the next. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.87%.

Volatility

Tsakos Energy Navigation Ltd's last day, last week, and last month's average volatility was a positive 0.45%, a negative 0.21%, and a positive 0.00%, respectively.

Tsakos Energy Navigation Ltd's last day, last week, and last month's high and low average amplitude percentage was 5.15%, 4.40%, and 4.80%, respectively.

Tsakos Energy Navigation Ltd's Stock Yearly Top and Bottom Value

Tsakos Energy Navigation Ltd's stock is valued at $8.88 at 19:23 EST, way below its 52-week high of $23.85 and way above its 52-week low of $7.06.

Tsakos Energy Navigation Ltd's Moving Average

Tsakos Energy Navigation Ltd's value is below its 50-day moving average of $8.92 and higher than its 200-day moving average of $8.58.

2. Jerash Holdings

47.62% Payout Ratio

Jerash Holdings (US), Inc., through its subsidiaries, manufactures and exports customized and ready-made sports and outerwear.

As claimed by Morningstar, Inc., the next dividend payment is on Nov 12, 2020, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 3.29%.

Jerash Holdings's sales growth this year is anticipated to be negative 8.7% and 10.9% for next year.

Year-on-year quarterly revenue growth declined by 11.5%, now sitting on 85.68M for the twelve trailing months.

Jerash Holdings's sales growth for the next quarter is 55.6%. The company's growth estimates for the present quarter and the next is negative 83.3% and 242.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.44%.

Volatility

Jerash Holdings's last day, last week, and last month's average volatility was a negative 2.53%, a negative 0.31%, and a positive 0.54%, respectively.

Jerash Holdings's last day, last week, and last month's high and low average amplitude percentage was 4.66%, 3.09%, and 3.40%, respectively.

Jerash Holdings's Stock Yearly Top and Bottom Value

Jerash Holdings's stock is valued at $5.92 at 19:23 EST, way below its 52-week high of $7.14 and way above its 52-week low of $3.60.

Jerash Holdings's Moving Average

Jerash Holdings's value is above its 50-day moving average of $5.58 and way higher than its 200-day moving average of $4.95.

3. Schnitzer Steel Industries, Inc.

122.95% Payout Ratio

Schnitzer Steel Industries, Inc. recycles ferrous and nonferrous scrap metals; and manufactures finished steel products worldwide.

As stated by Morningstar, Inc., the next dividend payment is on Jan 13, 2021, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 2.37%.

Schnitzer Steel Industries, Inc.'s sales growth this year is anticipated to be 42.9% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 21.3%, now sitting on 1.8B for the twelve trailing months.

Schnitzer Steel Industries, Inc.'s sales growth is 35.9% for the ongoing ongoing quarter and 88.6% for the next. The company's growth estimates for the present quarter and the next is 145.2% and 1200%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.85%.

Volatility

Schnitzer Steel Industries, Inc.'s last day, last week, and last month's average volatility was a positive 1.64%, a negative 1.04%, and a positive 0.28%, respectively.

Schnitzer Steel Industries, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 5.48%, 4.56%, and 5.32%, respectively.

Schnitzer Steel Industries, Inc.'s Stock Yearly Top and Bottom Value

Schnitzer Steel Industries, Inc.'s stock is valued at $31.59 at 19:23 EST, way below its 52-week high of $42.19 and way higher than its 52-week low of $10.09.

Schnitzer Steel Industries, Inc.'s Moving Average

Schnitzer Steel Industries, Inc.'s worth is under its 50-day moving average of $31.96 and way above its 200-day moving average of $23.21.

4. Utah Medical Products, Inc.

35.22% Payout Ratio

Utah Medical Products, Inc. manufactures and distributes medical devices for the healthcare industry in the United States, Europe, and internationally.

As maintained by Morningstar, Inc., the next dividend payment is on Dec 13, 2020, the estimated forward annual dividend rate is 1.14 and the estimated forward annual dividend yield is 1.31%.

Utah Medical Products, Inc.'s sales growth this year is anticipated to be negative 0% and a negative 0% for next year.

Year-on-year quarterly revenue growth declined by 16.1%, now sitting on 42M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.15%.

Volatility

Utah Medical Products, Inc.'s last day, last week, and last month's average volatility was a positive 1.00%, a negative 0.45%, and a positive 0.10%, respectively.

Utah Medical Products, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.02%, 3.09%, and 2.56%, respectively.

Utah Medical Products, Inc.'s Stock Yearly Top and Bottom Value

Utah Medical Products, Inc.'s stock is valued at $87.23 at 19:23 EST, way under its 52-week high of $109.00 and way above its 52-week low of $75.33.

Utah Medical Products, Inc.'s Moving Average

Utah Medical Products, Inc.'s value is below its 50-day moving average of $87.74 and above its 200-day moving average of $84.36.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com